Skip to main content
. 2019 May 22;21(4):66. doi: 10.1208/s12248-019-0332-z

Fig. 6.

Fig. 6

QSP model-based strategy for translating preclinical data for CD3 bispecific compounds to the clinic. “Biomeasures” can be defined as system-dependent parameters. TAA is a tumor-associated antigen